178 related articles for article (PubMed ID: 21545958)
1. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials.
Chen I; Motan T; Kiddoo D
J Minim Invasive Gynecol; 2011; 18(3):303-9. PubMed ID: 21545958
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
4. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
Kitade M; Kumakiri J; Kobori H; Murakami K
Trials; 2024 May; 25(1):343. PubMed ID: 38790029
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist therapy before myomectomy or hysterectomy.
Gutmann JN; Corson SL
J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
[No Abstract] [Full Text] [Related]
7. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial.
Vercellini P; Trespìdi L; Zaina B; Vicentini S; Stellato G; Crosignani PG
Fertil Steril; 2003 Jun; 79(6):1390-5. PubMed ID: 12798887
[TBL] [Abstract][Full Text] [Related]
8. Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.
de Milliano I; Huirne JAF; Thurkow AL; Radder C; Bongers MY; van Vliet H; van de Lande J; van de Ven PM; Hehenkamp WJK
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):89-98. PubMed ID: 31468503
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors.
Zullo F; Pellicano M; De Stefano R; Zupi E; Mastrantonio P
Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):108-12. PubMed ID: 9465812
[TBL] [Abstract][Full Text] [Related]
10. Patient selection for laparoscopic myomectomy.
Parker WH; Rodi IA
J Am Assoc Gynecol Laparosc; 1994 Nov; 2(1):23-6. PubMed ID: 9050528
[TBL] [Abstract][Full Text] [Related]
11. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
Lethaby A; Vollenhoven B; Sowter M
BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes after uterine artery occlusion at the time of myomectomy: systematic review and meta-analysis.
Sanders AP; Chan WV; Tang J; Murji A
Fertil Steril; 2019 Apr; 111(4):816-827.e4. PubMed ID: 30661604
[TBL] [Abstract][Full Text] [Related]
14. Experience with a gonadotrophin-releasing hormone agonist prior to myomectomy--comparison of twice- vs thrice-monthly doses and a control group.
Bassaw B; Mohammed N; Jaggat A; Singh-Bhola M; Ramkissoon A; Singh P; Jones K; Maharaj S; Ramsewak S
J Obstet Gynaecol; 2014 Jul; 34(5):415-9. PubMed ID: 24678813
[TBL] [Abstract][Full Text] [Related]
15. Combined Laparoscopic Uterine Artery Occlusion and Myomectomy versus Laparoscopic Myomectomy: A Direct-Comparison Meta-Analysis of Short- and Long-Term Outcomes in Women with Symptomatic Leiomyomas.
Tranoulis A; Georgiou D; Alazzam M; Borley J
J Minim Invasive Gynecol; 2019; 26(5):826-837. PubMed ID: 30776497
[TBL] [Abstract][Full Text] [Related]
16. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Kuhlmann M; Gärtner A; Schindler EM; Regidor PA; Bühler K; Schindler AE
Gynecol Endocrinol; 1997 Jun; 11(3):169-74. PubMed ID: 9209897
[TBL] [Abstract][Full Text] [Related]
17. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
[TBL] [Abstract][Full Text] [Related]
18. Gonadotrophin-releasing hormone agonist and laparoscopic myomectomy.
Dubuisson JB; Lecuru F; Foulot H; Mandelbrot L; Bouquet de la Jolinière J; Aubriot FX
Clin Ther; 1992; 14 Suppl A():51-6. PubMed ID: 1535022
[TBL] [Abstract][Full Text] [Related]
19. A Multicenter Study Evaluating the Effect of Ulipristal Acetate during Myomectomy.
Murji A; Wais M; Lee S; Pham A; Tai M; Liu G
J Minim Invasive Gynecol; 2018; 25(3):514-521. PubMed ID: 29079463
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of gonadotropin-releasing hormone agonist treatment before hysteroscopic myomectomy for large-sized submucosal leiomyoma.
Park M; Song MS; Kang BH; Song SY; Lee GW; Jung YW; Shin WK; Ko YB; Lee KH; Yoo HJ
Medicine (Baltimore); 2022 Aug; 101(31):e29726. PubMed ID: 35945797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
